Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cescon

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Transplantation Proceedings|February 23, 2010
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative periodC Zanfi, A Lauro, M Cescon, et al.
Transplantation Proceedings|August 19, 2007
Italian experience in adult clinical intestinal and multivisceral transplantation: 6 years laterA Lauro, C Zanfi, G Ercolani, et al.
The British Journal of Surgery|October 13, 2021
Repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma: retrospective multicentre studyJ-H Zhong, B-C Xing, W-G Zhang, et al.
Alimentary Pharmacology & Therapeutics|June 14, 2008
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantationF Lodato, S Berardi, A Gramenzi, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Transplantation Proceedings|February 23, 2010
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative periodC Zanfi, A Lauro, M Cescon, et al.
Transplantation Proceedings|August 19, 2007
Italian experience in adult clinical intestinal and multivisceral transplantation: 6 years laterA Lauro, C Zanfi, G Ercolani, et al.
The British Journal of Surgery|October 13, 2021
Repeat hepatic resection versus radiofrequency ablation for recurrent hepatocellular carcinoma: retrospective multicentre studyJ-H Zhong, B-C Xing, W-G Zhang, et al.
Alimentary Pharmacology & Therapeutics|June 14, 2008
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantationF Lodato, S Berardi, A Gramenzi, et al.
Pageof 7